Literature DB >> 11851338

Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sites.

Celia Schiffer1, Mark Ultsch, Scott Walsh, William Somers, Abraham M de Vos, Anthony Kossiakoff.   

Abstract

The structure of the ternary complex between the phage display- optimized, high-affinity Site 1 variant of human growth hormone (hGH) and two copies of the extracellular domain (ECD) of the hGH receptor (hGHR) has been determined at 2.6 A resolution. There are widespread and significant structural differences compared to the wild-type ternary hGH hGHR complex. The hGH variant (hGH(v)) contains 15 Site 1 mutations and binds>10(2) tighter to the hGHR ECD (hGH(R1)) at Site 1. It is biologically active and specific to hGHR. The hGH(v) Site 1 interface is somewhat smaller and 20% more hydrophobic compared to the wild-type (wt) counterpart. Of the ten hormone-receptor H-bonds in the site, only one is the same as in the wt complex. Additionally, several regions of hGH(v) structure move up to 9A in forming the interface. The contacts between the C-terminal domains of two receptor ECDs (hGH(R1)- hGH(R2)) are conserved; however, the large changes in Site 1 appear to cause global changes in the domains of hGH(R1) that affect the hGH(v)-hGH(R2) interface indirectly. This coupling is manifested by large changes in the conformation of groups participating in the Site 2 interaction and results in a structure for the site that is reorganized extensively. The hGH(v)- hGH(R2) interface contains seven H-bonds, only one of which is found in the wt complex. Several groups on hGH(v) and hGH(R2) undergo conformational changes of up to 8 A. Asp116 of hGH(v) plays a central role in the reorganization of Site 2 by forming two new H-bonds to the side-chains of Trp104(R2) and Trp169(R2), which are the key binding determinants of the receptor. The fact that a different binding solution is possible for Site 2, where there were no mutations or binding selection pressures, indicates that the structural elements found in these molecules possess an inherent functional plasticity that enables them to bind to a wide variety of binding surfaces. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11851338     DOI: 10.1006/jmbi.2001.5348

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Structural basis for recognition by an in vitro evolved affibody.

Authors:  Martin Högbom; Malin Eklund; Per-Ake Nygren; Pär Nordlund
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

2.  Obligate ordered binding of human lactogenic cytokines.

Authors:  Jeffery L Voorhees; Charles L Brooks
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

3.  Alternative views of functional protein binding epitopes obtained by combinatorial shotgun scanning mutagenesis.

Authors:  Gábor Pál; Shun-Yin Fong; Anthony A Kossiakoff; Sachdev S Sidhu
Journal:  Protein Sci       Date:  2005-09       Impact factor: 6.725

4.  Quantitative assessment of protein structural models by comparison of H/D exchange MS data with exchange behavior accurately predicted by DXCOREX.

Authors:  Tong Liu; Dennis Pantazatos; Sheng Li; Yoshitomo Hamuro; Vincent J Hilser; Virgil L Woods
Journal:  J Am Soc Mass Spectrom       Date:  2011-10-20       Impact factor: 3.109

Review 5.  Viral infection and human disease--insights from minimotifs.

Authors:  Krishna Kadaveru; Jay Vyas; Martin R Schiller
Journal:  Front Biosci       Date:  2008-05-01

6.  The high- and low-affinity receptor binding sites of growth hormone are allosterically coupled.

Authors:  Scott T R Walsh; Juliesta E Sylvester; Anthony A Kossiakoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

7.  Site2 binding energetics of the regulatory step of growth hormone-induced receptor homodimerization.

Authors:  Scott T R Walsh; Liz M Jevitts; Juliesta E Sylvester; Anthony A Kossiakoff
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.